VistaGen Therapeutics
VTGN
VTGN
43 hedge funds and large institutions have $56.3M invested in VistaGen Therapeutics in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 14 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
38% less capital invested
Capital invested by funds: $90.8M → $56.3M (-$34.5M)
50% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 14
Holders
43
Holding in Top 10
–
Calls
$2.09M
Puts
$606K
Top Buyers
| 1 | +$189K | |
| 2 | +$69.6K | |
| 3 | +$59K | |
| 4 |
VF
Virtu Financial
New York
|
+$54K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$50.6K |
Top Sellers
| 1 | -$1.15M | |
| 2 | -$779K | |
| 3 | -$475K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$398K |
| 5 |
Two Sigma Investments
New York
|
-$268K |